Manas AI raised $24.6 million in a seed round co-led by General Catalyst and Reid Hoffman to transform the discovery of novel cancer medicines.

Jan 27, 2025•7 months ago

Amount Raised

$24.6 Million

Round Type

seed

San FranciscoArtificial IntelligenceBiotechnology

Investors

GreylockReid HoffmanGeneral Catalyst

Description

Manas AI launched with a focus on transforming cancer and rare disease treatments through its AI-driven platform. The company aims to accelerate the development of new medicines, leveraging a partnership with Microsoft and a team of leading scientists.

Company Information

Company

Manas AI

Location

San Francisco, California, United States

About

Manas AI is an AI-driven company focused on discovering and advancing next-generation medicines. Co-founded by Dr. Siddhartha Mukherjee and Reid Hoffman, it integrates generative computational chemistry with AI to transform drug development timelines and costs. The company's mission is to accelerate the discovery and development of life-saving medicines, particularly for cancer and rare diseases. Its partnership with Microsoft leverages cloud computing and AI to enhance therapeutic discovery processes.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech